Previous close | 57.53 |
Open | 57.53 |
Bid | 61.95 |
Ask | 62.80 |
Strike | 120.00 |
Expiry date | 2025-01-17 |
Day's range | 57.53 - 57.53 |
Contract range | N/A |
Volume | |
Open interest | N/A |
PRINCETON, N.J., June 21, 2024--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with...
PRINCETON, N.J., June 21, 2024--European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab
PRINCETON, N.J., June 20, 2024--Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024